Interim report for the fourth quarter 2019, 1 January – 31 December 2019 Kancera AB (publ.), org.nr. 556806-8851.

by kancerawebedit | Mar 2, 2020

This is a translation of the report in Swedish.Fourth quarter in brief 1 October – 31 December 2019 Net sales for the period (January to December) amounted to SEK 3,24 million (0,4 million) of which the fourth quarter contributed SEK 0,0 million (0,3 million). R&D...

Delårsrapport Kancera AB (publ) för fjärde kvartalet 2019, 1 januari – 31 december 2019.

by kancerawebedit | Feb 21, 2020

Fjärde kvartalet i korthet 1 oktober – 31 december 2019 Nettoomsättning för perioden (januari till december) uppgick till 3,2 Mkr (0,4 Mkr) varav fjärde kvartalet utgjorde 0,0 Mkr (0,3 Mkr). FoU-kostnader för perioden uppgick till 34,5 Mkr (45,2 Mkr) varav fjärde...

Year End Report Kancera AB (publ) 1st January – 31st December 2018

by kancerawebedit | Mar 6, 2019

This is a translation of the Year End Report in Swedish published February 20th 2019.FOURTH QUARTER 1st OCTOBER – 31st DECEMBER IN BRIEF • Net sales for the period (January to December) amounted to SEK 0.4 million (SEK 0.1 million), of which the fourth quarter...

Bokslutskommuniké för Kancera AB (publ) 2018, 1 januari – 31 december 2018

by kancerawebedit | Feb 22, 2019

FJÄRDE KVARTALET 1 OKTOBER – 31 DECEMBER I KORTHET • Nettoomsättning för perioden (januari till december) uppgick till 0,4 MSEK (0,1 MSEK) varav fjärde kvartalet utgjorde 0,3 MSEK (0,0 MSEK). • FoU-kostnader för perioden uppgick till 45,2 Mkr (55,8 Mkr) varav fjärde...

YEAR END REPORT KANCERA  AB (publ) 1st January – 31st December 2017

by kancerawebedit | Feb 20, 2018

PERIOD 1 JAN – 31 DEC 2017 IN BRIEF • Net turnover for the period amounted to SEK 0.1 million (0.3 million). For the fourth quarter, turnover amounted to 0.0 MEK (0.1 M). • R & D expenses for the period amounted to SEK 51.1 million (19.1 million), of which...